Cigna price target raised to $400 from $385 at UBS

UBS raised the firm’s price target on Cigna to $400 from $385 and keeps a Buy rating on the shares. At its investor Day, Cigna detailed the inputs that drive its long-term growth outlook which now calls for long-term EPS growth of 10%-14%, with a key point that the company believes it can post consistent superior growth relative to peers, even with no health insurance offerings in government businesses, the analyst tells investors in a research note.